Thanks Cortinaboy, and all valid points.
As I said there is still risk, but the risk reward ratio being factored by the market is too negative in my opinion.
With success we have a multi billion dollar product. The current value of the company attributes about a 1% chance of success. I rate it much higher. In fact I rate our chances of success in Retts or FragileX as higher than the chances of failure.
But regardless of that, it's all about an investment. Even at 6c the upside is enormous, not just from clinical success, but from a partnership or deal - which is most likely to happen in my opinion.
I still have caution though.
Cheers and thanks for your input.
Thanks Cortinaboy, and all valid points.As I said there is still...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.02 |
Change
-0.260(1.82%) |
Mkt cap ! $1.745B | |||
| Open | High | Low | Value | Volume |
| $14.44 | $14.44 | $14.00 | $3.454M | 245.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 7440 | $14.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.11 | 3159 | 1 |
View Market Depth
| Last trade - 16.10pm 07/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |